Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy (Q40914451)
scientific article
Language:
(P31) (Q13442814)
(P304) 5842-5848
(P407) (Q1860)
(P433) 22
(P478) 59
(P577) Monday, November 1, 1999
(P921) (Q410395)
(P1433) (Q326097)
(P1476) "Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy" (language: en)
(P2093) X Z Wang
J R Beebe
L Pwiti
A Bielawska
M J Smyth
other details
description scientific article

External Links